Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04259125 · ClinicalTrials.gov registry record
Evaluating the Role of Inflammation in Neonatal Epileptogenesis
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 72
- Enrollment target
NCT04259125 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 72 participants.
The verdict
NCT04259125 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
Study Summary
The purpose of this study evaluate the relationship between inflammation and epilepsy in neonates with seizures after birth.
Interventions
- DIAGNOSTIC_TEST Blood draw
- OTHER Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2018-12-15 |
| Est. Completion | 2025-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04259125
The ClinicalTrials.gov registry entry for NCT04259125 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood draw is the first listed.
NCT04259125 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04259125 about?
NCT04259125 is a clinical study titled "Evaluating the Role of Inflammation in Neonatal Epileptogenesis". The purpose of this study evaluate the relationship between inflammation and epilepsy in neonates with seizures after birth.
What is the current status of trial NCT04259125?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2018-12-15. Estimated completion is 2025-12-01.
What interventions are being tested in trial NCT04259125?
The interventions under investigation include: Blood draw (DIAGNOSTIC_TEST), Survey (OTHER).
Who is sponsoring clinical trial NCT04259125?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.